Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma

William A. Hall; Jiahe Li; Y. Nancy You; Marc J. Gollub; Joseph R. Grajo; Mark Rosen; Greg dePrisco; Greg Yothers; Jennifer A. Dorth; Osama E. Rahma; Marcia M. Russell; Howard M. Gross; Samuel A. Jacobs; Bryan A. Faller; Sagila George; Tareq Al Baghdadi; Michael G. Haddock; Richard K. Valicenti; Theodore S. Hong; Thomas J. George

doi:10.1200/jco.22.02525

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

MRI alone is a poor tool to distinguish pCR in rectal adenocarcinoma undergoing TNT. However, the MR-TRG score presents a now validated method, correlated with pathologic NAR, which can objectively measure regression magnitude during TNT.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hall et al. (2023) studied this question.

synapsesocial.com/papers/69d8904205ee2ba81dbefbf6 https://doi.org/10.1200/jco.22.02525

View Full Paper

Ask AI

Bookmark

Share

Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma

Ask about this paper

Abstract

Discussion

Cite This Study

Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading